Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for
Advanced Malignant Tumors
Location: Quebec, Hackensack NJ, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06764771

Phase 1, Recruiting

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A

for
Solid Tumors
Location: San Antonio TX
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT03950297

Phase 1, Recruiting

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

for
Adenocarincoma of Pancreas, Stage III Pancreatic Cancer,
Location: Seattle WA
Sponsor: Seattle Cancer Treatment and Wellness Center

Sex: All

Age: 18 - 65

Code: NCT00323583

Phase 2, Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

for
Non Small Cell Lung Cancer,
Location: Boston MA, Austin, TX 78758 TX, San Antonio TX
Sponsor: Zumutor Biologics Inc.

Sex: All

Age: 18+

Code: NCT06451497

Phase 1, Recruiting

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

for
Cancer, Breast, Cancer, Lung, Cancer of Pancreas,
Location: Manhasset NY, Orlando FL, Cerritos CA
Sponsor: Coherent Biopharma (Hefei) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05830097

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of Grief Therapy Approaches for Bereaved Parents

for
Grief, Bereavement, Cancer
Location: New York NY, Philadelphia PA, Memphis TN, Stanford CA
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05142605

Recruiting

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Detroit MI, Nashville TN, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All

Age: 18+

Code: NCT05886920

Phase 1, Phase 2, Recruiting

STABLE (Strength Training and Balance Leg Exercise) Study

for
Neoplasms
Location: Edmonton
Sponsor: University of Saskatchewan

Sex: All

Age: 65+

Code: NCT04518098

Recruiting

Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

for
Pancreatic Adenocarcinoma
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18 - 70+

Code: NCT04452461

Phase 2, Recruiting

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

for
Cancer
Location: Fairfax VA
Sponsor: Inova Health Care Services

Sex: All

Age: 35 - 70+

Code: NCT06931561

Recruiting

STING MARK Universal Fiducial Marker System

for
Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT05465161

Recruiting

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT02215928

Recruiting

BOLSTER: Learning New Skills to Thrive

for
Gastrointestinal Cancer, Gynecologic Cancer, Advanced Cancer
Location: Boston MA, Houston TX
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06936878

Recruiting

A Study in Patients With Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Location: Fairfax VA, Houston TX, Austin TX
Sponsor: BiOneCure Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05320588

Phase 1, Phase 2, Recruiting

Resilience-Building for Advance Care Planning

for
Advanced Cancer, End of Life
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT07428278

Recruiting

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07541365

Recruiting

Patient Reported Outcomes/Metrics Program Trial

for
Metastatic Cancer, Palliative
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04983199

Recruiting

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

for
Solid Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04665388

Recruiting

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

for
COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 39

Code: NCT04551378

Recruiting

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

for
Brain Cancer, Glioblastoma, Metastatic Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06058988

Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial